RxDoctor Payments DataLook up a doctor →

Edwin Diaz

Nurse Practitioner · Tampa, FLNPI 1821755257

Payments from drug & device makers

$21,280in general payments, 2019–2025

Across 1,074 payments — averaging $19.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$2K
  • AstraZeneca$2K
  • Inspire Medical Systems, Inc.$1K
  • Jazz Pharmaceuticals Inc.$1K
  • Amgen$1K
  • AbbVie$803
  • plus $12K from 54 others

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
GSK113$2,420
AstraZeneca(2 entities)89$1,935
Inspire Medical Systems, Inc.14$1,479
Jazz Pharmaceuticals Inc.52$1,076
Amgen(2 entities)57$1,051
AbbVie43$803
Biohaven Pharmaceutical Holding Company Ltd.31$723
Takeda Pharmaceuticals U.S.A., Inc.27$619
Inari Medical, Inc.29$597
Boehringer Ingelheim25$556
Neurocrine Biosciences, Inc.41$502
Regeneron Healthcare Solutions, Inc.18$473
Stryker36$413
Harmony Biosciences LLC21$399
United Therapeutics Corporation17$367
Bristol Myers Squibb31$355
Octapharma USA, Inc.9$325
Lilly USA, LLC21$318
Pfizer22$301
Acorda Therapeutics, Inc17$297
Grifols USA, LLC14$290
Avadel CNS Pharmaceuticals, LLC9$289
Teva Pharmaceuticals USA, Inc.23$285
Impel Pharmaceuticals Inc.16$278
Eisai Inc.20$263
SK Life Science, Inc.14$245
MDD US Operations, LLC19$237
UCB, Inc.14$235
Sunovion Pharmaceuticals Inc.15$234
Sanofi10$233
Kyowa Kirin, Inc.6$208
Biogen14$205
Amneal Pharmaceuticals LLC12$194
Novartis11$187
Verona Pharma, Inc.13$180
Lundbeck LLC9$177
E.r. Squibb & Sons, L.L.C.2$167
Corium, LLC10$161
Actelion Pharmaceuticals US, Inc.9$160
Sumitomo Pharma America, Inc.13$148
Otsuka America Pharmaceutical, Inc.15$146
Insmed, Inc.7$145
Johnson & Johnson7$142
Merck6$142
Banner Life Sciences, LLC7$102
Electromed, Inc.8$102
ANI Pharmaceuticals, Inc.5$101
Azurity Pharmaceuticals, Inc.5$98
Sanofi-aventis U.S. LLC1$85
Avanir Pharmaceuticals, Inc.5$83
Argenx US, Inc.5$81
Mallinckrodt Hospital Products Inc.3$65
Philips North America LLC3$59
Supernus Pharmaceuticals, Inc.4$58
Baxter Healthcare3$55
CSL Behring3$48
Mylan Specialty L.p.2$44
Scilex Pharmaceuticals Inc.2$43
Upsher-smith Laboratories LLC2$37
Neurelis, Inc.2$32

How this compares

$21,280 in reported general payments places this provider in the 95th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida →

Medicare billing

Part B allowed, 2024
$81,559
Medicare patients
459
Services billed
863

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in Tampa

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →